Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Hanash

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphomaEhsan Irajizad, Johannes F Fahrmann, Hiroyuki Katayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2025
Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyamine Metabolism as a Biomarker of ProgressionRicardo A León-Letelier, Yihui Chen, Rongzhang Dou, et al.
Science Translational Medicine|April 8, 2010
Elafin is a biomarker of graft-versus-host disease of the skinSophie Paczesny, Thomas M Braun, John E Levine, et al.
Nature Medicine|July 16, 2002
Gene-expression profiles predict survival of patients with lung adenocarcinomaDavid G Beer, Sharon L R Kardia, Chiang-Ching Huang, et al.
Cancer Immunology Research|May 17, 2018
IL22 Promotes <i>Kras</i>-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness PropertiesNasim Khosravi, Mauricio S Caetano, Amber M Cumpian, et al.
Journal of the National Cancer Institute|August 24, 2018
A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic CancerJohannes F Fahrmann, Leonidas E Bantis, Michela Capello, et al.
Cancers|May 28, 2022
Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung AdenocarcinomaJohannes F Fahrmann, Ichidai Tanaka, Ehsan Irajizad, et al.
Cancer Immunology Research|March 4, 2017
Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer CellsHaley L Peters, Satyendra C Tripathi, Celine Kerros, et al.
Cell Reports. Medicine|December 17, 2025
Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancerJody Vykoukal, Yihui Chen, Mingxin Zuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarraysKevin K Dobbin, David G Beer, Matthew Meyerson, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphomaEhsan Irajizad, Johannes F Fahrmann, Hiroyuki Katayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2025
Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyamine Metabolism as a Biomarker of ProgressionRicardo A León-Letelier, Yihui Chen, Rongzhang Dou, et al.
Science Translational Medicine|April 8, 2010
Elafin is a biomarker of graft-versus-host disease of the skinSophie Paczesny, Thomas M Braun, John E Levine, et al.
Nature Medicine|July 16, 2002
Gene-expression profiles predict survival of patients with lung adenocarcinomaDavid G Beer, Sharon L R Kardia, Chiang-Ching Huang, et al.
Cancer Immunology Research|May 17, 2018
IL22 Promotes <i>Kras</i>-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness PropertiesNasim Khosravi, Mauricio S Caetano, Amber M Cumpian, et al.
Journal of the National Cancer Institute|August 24, 2018
A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic CancerJohannes F Fahrmann, Leonidas E Bantis, Michela Capello, et al.
Cancers|May 28, 2022
Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung AdenocarcinomaJohannes F Fahrmann, Ichidai Tanaka, Ehsan Irajizad, et al.
Cancer Immunology Research|March 4, 2017
Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer CellsHaley L Peters, Satyendra C Tripathi, Celine Kerros, et al.
Cell Reports. Medicine|December 17, 2025
Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancerJody Vykoukal, Yihui Chen, Mingxin Zuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarraysKevin K Dobbin, David G Beer, Matthew Meyerson, et al.
Pageof 17